01 14Valeant Canada LP
02 11Valeant Canada LP / Valeant Canada S.E.C.
01 102111085
02 102242224
03 52307547
01 25Diltiazem Hydrochloride
01 10Capsule
02 15Tablet
01 102012-06-25
02 102016-12-23
03 52020-05-04
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Brand Name : TIAZAC
Patent Number : 2242224
Filing Date : 1996-12-23
Strength per Unit : 120 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Brand Name : TIAZAC
Patent Number : 2242224
Filing Date : 1996-12-23
Strength per Unit : 180 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Brand Name : TIAZAC
Patent Number : 2242224
Filing Date : 1996-12-23
Strength per Unit : 240 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Brand Name : TIAZAC
Patent Number : 2242224
Filing Date : 1996-12-23
Strength per Unit : 300 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Brand Name : TIAZAC
Patent Number : 2242224
Filing Date : 1996-12-23
Strength per Unit : 360 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-23
Date Granted : 2004-01-13
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Brand Name : TIAZAC XC
Patent Number : 2307547
Filing Date : 2000-05-04
Strength per Unit : 120 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Brand Name : TIAZAC XC
Patent Number : 2307547
Filing Date : 2000-05-04
Strength per Unit : 180 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Brand Name : TIAZAC XC
Patent Number : 2307547
Filing Date : 2000-05-04
Strength per Unit : 240 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Brand Name : TIAZAC XC
Patent Number : 2307547
Filing Date : 2000-05-04
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
Brand Name : TIAZAC XC
Patent Number : 2307547
Filing Date : 2000-05-04
Strength per Unit : 360 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-05-04
Date Granted : 2007-08-14
LOOKING FOR A SUPPLIER?
